BRCA1-associated structural variations are a consequence of polymerase theta-mediated end-joining
Cancer mutational signatures have been associated with defects in genome maintenance pathways. Here the authors, by using a worm germline mutagenesis model defective of human orthologue BRCA-1, identify polymerase theta-mediated end-joining (TMEJ) as causing the BRCAness mutational signature.
Enregistré dans:
Auteurs principaux: | J. A. Kamp, R. van Schendel, I. W. Dilweg, M. Tijsterman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7e9ffb55af7f4b2f9a5cfebaf60ef6ca |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
BRCA2 antagonizes classical and alternative nonhomologous end-joining to prevent gross genomic instability
par: Jinhua Han, et autres
Publié: (2017) -
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining
par: Tzah Feldman, et autres
Publié: (2021) -
Genetic determinants of cellular addiction to DNA polymerase theta
par: Wanjuan Feng, et autres
Publié: (2019) -
Molecular basis of microhomology-mediated end-joining by purified full-length Polθ
par: Samuel J. Black, et autres
Publié: (2019) -
Clinical consequences of BRCA2 hypomorphism
par: Laia Castells-Roca, et autres
Publié: (2021)